Scranton BusinessesThe Amsterdam-based came to the fore when it announced the acquisition of a historic Spanish basketball club for 3.7 million in 2018: Youth of Badalona. La Penya, colloquially known as the green-and-black club, is part of one of the mostly family-controlled investment holdings. grifols and directors and directors of the blood plasma company Tomas Dagafounder of law firm osborne clarke. It has 76% of the cava producer in its portfolio. Juve and the Camps share up wallapop More diverse companies, including healthcare and real estate in Madrid and Barcelona.
Scranton controls 8.13% at Grifols. To this percentage should be added the shares of two other instrumental companies of family members: Thortholowning 7.09% and leatherwith 9.20%. Nuria Rouramother of the current honorary president Victor Grifols Roura Adds another 6.15%. In total, reported to the National Exchange Commission: 30.5%.
From an unknown laboratory founded in 1909 specializing in blood therapy, Grifols has grown into one of the most attractive companies on the stock market. In 2008, two years after listing, on Ibex35. Investors supported the group’s strategy and increased the value of its shares to €34 with a capital of 23,000 million. Headed by Víctor Grifols Roura, the company embarked on a market-acclaimed series of acquisitions and international expansions. In June 2010, it announced its acquisition of American. storyteller for 3,000 million euros. The closure of the operation the following year allows Grifols to be listed on the Nasdaq Wall Street index. Leaking of documents in 2010 WikiLeaks He estimates that one of the strategic poles in Europe for the United States is the town of Parets del Vallès (Barcelona), the headquarters of the plasma factory. Bloodwork and the results of blood therapy to treat diseases began to generate more than just interest.
Grifols is growing overseas and diversifying its businesses – for example, betting on Alzheimer’s-fighting research – financing itself with the cheapest formula it has available: debt. So were other companies that set great growth prospects: operators of telecommunications towers, mobile phone, and the world leader in swimming pools, fluid.
In the middle of the wave, the Grifols family, who bonded together as sympathizers of the independence movement, changed the dome. In 2017, president Víctor Grifols Roura handed over executive powers to his brother. Raimon Grifolsand his son, Victor Grifols Deu. Both positions are fairly new to the Board Sanhedrin: CEO of Executive Solidarity. Former US ambassador to Spain in a dramatic blow in 2020, James Costs.
In April 2022, Grifols acquired the most controversial acquisition: the German company Biotest for 1.413 million. The company’s debt has grown to over 9,000 million and represents nine times the ebitda (earnings before interest, taxes, provisions and depreciation), a rate currently considered high risk for investors. The apparent rate increase and funds begin to punish the sinking action. Grifols loses two-thirds of its value. An already withdrawn demand for ex-donors in the United States and the fact that 30% of plasma from donors at the so-called border with Mexico has fallen due to the pandemic complicates its image.
The blood had reached the river, and the council decided to stage a coup. Director in October 2022 Steven Mayermutual fund experience Cerberus He became executive chairman of Raimon Grifols and Víctor Grifols Deu. His father becomes honorary president. The company announced that its net debt reached 9,390 million in the first nine months of the year and it intends to quadruple EBITDA over the next 18 months (estimated at one billion by 2022). Estimated sales for the year – announced February 28 results – are forecast to reach 6,000 million with a net liquidity of 1,570 million. “There will be no more corporate operations or cash dividend payments until debt is reduced,” says Grifols. The good news: Donated plasma volume increased 25% in nine months.
Related news
Last week, Grifols announced an accident plan: 2,200 layoffs in the US and 100 in Spain, 8% of the workforce. The stock market is celebrating this with gains of up to 8%. Cost: 140 million. The company announced that it “continues to consider transactional alternatives to reduce its indebtedness.”
This Tuesday, new announcement. Steven F. Mayer decides to resign for health and personal reasons. As chief executive, another board member: Thomas Glanzmann. Raimon Grifols was promoted to Vice President. Another band-aid?